COMMUNIQUÉS West-GlobeNewswire

EchoNous Announces Full Launch of Kosmos 2.2 Update on Apple iOS, Featuring Revolutionary Workflow Enhancements
26/08/2024
REDMOND, Wash., Aug. 26, 2024 (GLOBE NEWSWIRE) -- EchoNous, a leading innovator in ultrasound technology, is pleased to announce the full launch of the highly anticipated Kosmos 2.2 update, now available on Apple iOS. [...]
Novo Nordisk A/S - share repurchase programme
26/08/2024
Bagsværd, Denmark, 26 August 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
EURneffy (adrenaline nasal spray) Approved in the EU as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
26/08/2024
EURneffy offers adults and children (≥30 kg) in Europe living with severe allergic reactions the first new delivery method for adrenaline in more than 30 years in the EU European Commission decision follows FDA approval [...]
Healthcare Integrated Technologies, Inc. Welcomes Micheal J. Burt to its Board of Directors
26/08/2024
Knoxville, Tennessee, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator in healthcare solutions, is proud to announce the appointment of Micheal J. Burt to its [...]
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
26/08/2024
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its participation in the Morgan Stanley 22nd Annual Global [...]
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
26/08/2024
REYKJAVIK, Iceland, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its [...]
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024
26/08/2024
SOUTH SAN FRANCISCO, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the [...]
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
26/08/2024
YARDLEY, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its [...]
Positron Corporation Announces Sale of NeuSight PET-CT Scanner
26/08/2024
Niagara Falls, NY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]
Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11
26/08/2024
TORONTO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain [...]
Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amyotrophic Lateral Sclerosis (ALS)
26/08/2024
Grant to support the in vivo development of first-in-class condensate-modifying drugs (c-mods) targeting the TDP-43 condensatopathy in ALS BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. , the [...]
EverythingALS Launches New Mobile App: A Comprehensive Research and Life Navigation Tool for the ALS Community
26/08/2024
SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) -- EverythingALS is proud to announce the launch of its new mobile app, now available on both the iOS and Android marketplaces. This app represents a significant upgrade from the [...]
Le KFSHRC établit de nouvelles normes mondiales en matière de formation aux soins de santé numériques
25/08/2024
RIYAD, Arabie saoudite, 25 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) tire parti de technologies innovantes pour améliorer l’éducation et la formation médicales en [...]
Innovative Training and Simulation Propel KFSHRC to Global Leadership in Medical Education
25/08/2024
RIYADH, Saudi Arabia, Aug. 25, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing clinical training through its iLearn Portal and comprehensive simulation-based [...]
KFSHRC Sets New Global Standards in Digital Healthcare Education
24/08/2024
RIYADH, Saudi Arabia, Aug. 24, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is leveraging innovative technologies to enhance medical education and training, rolling out ground- [...]
Le KFSHRC propose des programmes de recherche innovants aux futurs leaders du secteur de la santé
24/08/2024
RIYAD, Arabie saoudite, 24 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) renforce sa position de leader dans l’éducation et la recherche médicale grâce à son Département [...]
Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies
24/08/2024
NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen TOKYO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Koji Eguchi; listed on [...]
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24/08/2024
SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced [...]
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
23/08/2024
FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications [...]

Pages